i3 Drug Safety’s industry-renowned scientists, researchers, and associated professionals have
published numerous articles in peer-reviewed journals and given acclaimed presentations at
conferences worldwide.
| |
|
Authors:
Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT.
Title:
Comorbidities in Patients with Persistent or Chronic Immune Thrombocytopenia (ITP).
Publication:
Int J Hematol. July 2010;DOI: 10.1007/s12185-010-0636-3.
|
|
Authors:
Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD
Title:
Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States
Publication:
Pediatrics, Vol. 125 No. 2 February 2010, pp. e208-e213 (doi:10.1542/peds.2009-1246)
|
|
Authors:
Amend KL, Turnbull B, Foskett N, Napalkov P, Kurth T, Seeger JD
Title:
Incidence of progressive multifocal leukoencephalopathy in patients without HIV
Publication:
Neurology. In press
|
|
Authors:
Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L,McAfee AT
Title:
Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy
Publication:
American Journal of Cardiology. In press.
|
|
Authors:
Funch, D, Norman H, Wong J, Bennett R, Hillier J, Al-Sabbah A, Seeger JD
Title:
Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: A healthcare claims database study supplemented with medical records—The RETRO Study
Publication:
Pharmacoepidemiology and Drug Safety, 19: 448–456. doi: 10.1002/pds.1918
|
|
Authors:
Dore, D, Norman H, Seeger JD
Title:
Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users (Letter)
Publication:
Obstetrics & Gynecology 2009 Jul; 114(1):175.
|
|
Authors:
Dore D, Norman H, Loughlin J , Seeger JD
Title:
Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users
Publication:
Contraception. 2010 May; 81(5): 408-13.
|
|
Authors:
Loughlin J, Quinn S , Rivero E, Wong J, Huang J, Kralstein J, Earnest DL, Seeger JD
Title:
Tegaserod and the risk of cardiovascular ischemic events: An observational cohort study
Publication:
Journal of Cardiovascular Pharmacology and Therapeutics, 2010; 15(2): 151-7.
|
|
Authors:
Platt R, Wilson M, Chan KA , Benner JS, Marchibroda J, McClellan M
Title:
The new Sentinel Network – improving the evidence of medical-product safety
Publication:
New England Journal of Medicine 2009; 361;7:645-7.
|
|
Authors:
Brown JS, Moore KM, Braun MM, Ziyadeh N, Chan KA, Lee GM, Kulldorff M
Title:
Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
Publication:
Medical Care 2009, 47(12):1251-1257
|
View
a complete list of peer-reviewed scientific publications from i3 Drug Safety
| Conference/Event - Location |
Date |
Presenter |
Title/Topic |
Type |
| ISPOR, Atlanta, GA |
May-10 |
John Seeger |
Prospensity Scores and Observational Studies of Treatment Effect |
Pre-conference workshop |
| World Vaccines Congress, Washington, DC |
Apr-10 |
Arnold Chan |
Understand the depth and breadth of pharmacovigilance: pre- and post-licensure signal detection |
Conference panel presentation |
| Partnerships with Clinical Trials Conference, Orlando, FL |
Apr-10 |
Arnold Chan |
There's a New Sheriff in Town: Bridging the Gap between Safety and Clinical Research |
Session presenter |
| ISPE Mid-year Meeting, Raleigh, NC |
Apr-10 |
Andrew McAfee |
Introduction to Pharmacoepidemiology: Cohort Studies |
Short course |
9th Annual DIA Conference on Contemporary Pharmacovigilance and Risk Management Strategies
Washington, DC |
Jan-10 |
Andy McAfee |
Applied Epidemiology Techniques for Pharmacovigilance Risk Management |
Tutorial |
ACPE (Asian Conference on Pharmacoepidemiology)
Tainan, TW |
Oct-09 |
Arnold Chan |
Introduction to Pharmacoepidemiology |
Presentation |
| Arnold Chan |
Pharmacoepidemiology Methods |
Presentation |
| Arnold Chan |
Using database in pharmacoepidemiologic research: ethical concern, data mining and validation |
Presentation |
5th JMDC Medical Data Seminar
Tokyo, JP |
Oct-09 |
Arnold Chan |
Use of Health Insurance Claims data in Pharmaceutical Industry |
Presentation |
NESUG
Burlington, VT |
Sep-09 |
Rob Gately |
Incidence-Density Sampling: Alternative Programming Approaches to Achieve the Same End |
Oral presentation |
ISPE - International Conference on Pharmacoepidemiology
Providence, RI |
Aug-09 |
Andrew McAfee |
Introduction to Pharmacoepidemiology |
Workshop presentation |
| David Dore |
Extended Results on the Risk of Venous Thromboembolism (VTE), Myocardial Infarction (MI), and Stroke in Users of Transdermal Norelgestromin/Ethinyl Estradiol (patch) |
Oral Presentation |
| Jeanne Loughlin |
No Evidence for Association of Tegaserod with Adverse Cardiovascular Ischemic Events |
Oral Presentation |
| Florence Wang |
Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United States: A Claims-Based Analysis |
Oral Presentation |
| Najat Ziyadeh |
Effect of Extended Mortality Ascertainment in a Cohort Study of the Risk of Cancer in Regranex (Becaplermin) Users and Matched Comparators |
Oral Presentation |
| Jeanne Loughlin |
A Post-Marketing Surveillance Program for Pentavalent Rotavirus Vaccine |
Oral Presentation |
| Arnold Chan |
Workshop: Automated Data Sources for Pharmacoepidemiology in Asia-Pacific Region: Updates and Perspectives |
Workshop presentation |
| Kandace Amend |
Characteristics of Patients with DME, RVO, and Uveitis |
Poster |
| Wendy Carman |
Factors Associated with Changes in Management of Benign Prostatic Hyperplasia: Longitudinal Data from the BPH Registry |
Poster |
| Wendy Carman |
Longitudinal Changes in Lower Urinary Tract Symptoms in Men Managed for Benign Prostatic Hyperplasia |
Poster |
| David Dore |
Active Safety Surveillance of the Risk of Acute Pancreatitis (AP) Associated with Exenatide or Sitagliptin Compared to Metformin or Glyburide |
Poster |
| David Dore |
Enhanced Oncology Applications of Health Insurance Claims Data through Clinical Data Linkage |
Poster |
| John Seeger |
Hepatic Events in Duloxetine Users Compared to Other Depressed and Non-Depressed Subjects |
Poster |
| John Seeger |
Cardiovascular Events in Duloxetine Users Compared to Other Depressed and Non-Depressed Subjects |
Poster |
| David Dore |
Positive Predictive Value (PPV) of Commercial Health Insurance Claims Data for Identifying Acute Pancreatitis (AP) in Patients with Diabetes Mellitus (DM) |
Oral presentation |
| Cheryl Enger |
Risk of Hematological Malignancy among Persons with Chronic Idiopathic Thrombocytopenia Purpura |
Poster |
| Jeanne Loughlin |
No Evidence for Association of Tegaserod with Suicide-Related Outcomes |
Poster |
| David Dore |
Incidence of Acute Pancreatitis in Exenatide Initiators Compared to Other Antidiabetic Drug Initiators: A Retrospective Cohort Study |
Oral presentation |
| Kandace Amend |
Trends in LABA Prescription Patterns |
Poster |
| David Dore |
Medical Record Abstraction to Supplement Covariate Data in Health Insurance Claims: The Case of Diabetes and Acute Pancreatitis (AP) |
Poster |
| Cheryl Enger |
Risk of Thromboembolic Events among Persons with Chronic Idiopathic Thrombocytopenia Purpura |
Poster |
| John Seeger |
Atomoxetine and Cerebrovascular Outcomes in Adults |
Poster |
| Jeanne Loughlin |
Adherence to the Pentavalent Rotavirus Vaccine Dosing Schedule in the U.S.: 2006-2007 |
Poster |
ISPOR
Orlando, FL |
May-09 |
John Seeger |
Propensity score workshop |
Presentation |
World Drug Safety Congress
Washington, DC |
Apr-09 |
Arnold Chan |
Prospective monitoring beyond spontaneous reporting |
Presentation |
SAWC - Seminars in advanced wound care
Dallas, TX |
Apr-09 |
Arnold Chan |
Becaplermin and Cancer Safety |
Presentation |
ISPE midyear
Stockholm, SE |
Apr-09 |
John Seeger |
Time-varying propensity scores |
Presentation |
CBI Drug Safety Forum
Arlington, VA |
Mar-09 |
Arnold Chan |
Medical product safety surveillance |
Presentation |
5th China Shanghai International Conference Pharmacoepidemiology and Clinical Drug Rational Use
Xiamen, CN |
Mar-09 |
Arnold Chan |
Real Life Drug Studies |
Presentation |
PMDA (Pharmaceuticals and Medical Device Agency)
Tokyo, JP |
Feb-09 |
Arnold Chan |
Medical product safety surveillance |
Presentation | |
|
|
